about
Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction.Shift of circadian feeding pattern by high-fat diets is coincident with reward deficits in obese mice.Targeting the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta signaling pathway to limit neurotoxicity induced by drug abuse.Identification of new drug targets and biomarkers related to obesity and eating disorders: an approach based on reward deficit and addiction.Target identification and validation in brain reward dysfunction.A high-fat diet combined with food deprivation increases food seeking and the expression of candidate biomarkers of addiction.Behavioral and in vitro evaluation of tetrodotoxin tolerability for therapeutic applications.Mediterranean diet and childhood asthma.Tecoma sambucifolia: anti-inflammatory and antinociceptive activities, and 'in vitro' toxicity of extracts of the 'huarumo' of peruvian incas.Introducing the neurosciences section of the Journal of Translational Medicine.The neurotrophic factor pleiotrophin modulates amphetamine-seeking behaviour and amphetamine-induced neurotoxic effects: evidence from pleiotrophin knockout mice.Effects of yohimbine on morphine analgesia and physical dependence in the rat.Different pattern of pleiotrophin and midkine expression in neuropathic pain: correlation between changes in pleiotrophin gene expression and rat strain differences in neuropathic pain.Synthesis and biological evaluation of novel 2-(1H-imidazol-4-yl)cyclopropane carboxylic acids: key intermediates for H3 histamine receptor ligands.The contribution of alpha2-adrenoceptor and opioid receptor mechanisms to antinociception differs in Lewis and Fischer 344 rats.Differences of mu-opioid receptors between Lewis and F344 rats.Social deprivation stress induces adaptative changes of opioid mechanisms in the rat tail artery.Undernutrition upregulates fumarate hydratase in the rat nucleus accumbens.Pleiotrophin inhibits hippocampal long-term potentiation: a role of pleiotrophin in learning and memory.CONSENSUS DOCUMENT AND CONCLUSIONS - Obesity and sedentarism in the 21st century: what can be done and what must be done?Cocaine facilitates protein synthesis-dependent LTP: the role of metabotropic glutamate receptors.Genetic differences in hippocampal synaptic plasticity.Histamine H3 receptor desensitization in the guinea-pig ileum.Relapse to opiate use provokes biphasic changes of blood pressure in heroin-withdrawn addicts treated with clonidine.Effect of morphine and acetylcholine on contractile activity and cyclic AMP in guinea-pig ileum.Pleiotrophin prevents cocaine-induced toxicity in vitro.The alpha2-adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration.Comparative study of alpha2-adrenoceptors in Fischer 344 and Lewis rats. Evidence for clonidine-induced place aversion.Noradrenergic and opioidergic alterations in neuropathy in different rat strains.Lewis and Fischer 344 strain differences in alpha2-adrenoceptors and tyrosine hydroxylase expression.Differential regulation of CDK5 and c-Fos expression by morphine in the brain of Lewis and Fischer 344 rat strains.Bioactive properties of Tynanthus panurensis (Bureau) Sanwith bark extract, the Amazonian "clavo huasca".Assessing addiction vulnerability with different rat strains and place preference procedures: the role of the cocaine and amphetamine-regulated transcript.Morphine differentially regulates hsp90beta expression in the nucleus accumbens of Lewis and Fischer 344 rats.Changes in BDNF gene expression correlate with rat strain differences in neuropathic pain.Effects of chronic cocaine administration on spatial learning and hippocampal spine density in two genetically different strains of rats.Morphine and yohimbine regulate midkine gene expression in the rat hippocampus.Yohimbine prevents morphine-induced changes of glial fibrillary acidic protein in brainstem and alpha2-adrenoceptor gene expression in hippocampus.Place conditioning in a two- or three-conditioning compartment apparatus: a comparative study with morphine and U-50,488.Subcutaneous tetrodotoxin and inflammatory pain.
P50
Q33434961-EDC709E2-F5BE-4C07-AA6A-5D3D4AD2F4E9Q34263237-FEF06C7F-4D52-4600-812F-5D7A6A4A3CE2Q37438616-17D91E3F-3A19-4C92-B4A2-A4DB61B606EBQ37849789-2E701C7B-E54D-4458-924A-941778BC2943Q38300995-6F65B6CB-43C8-4A5E-917B-C3B02A3C50E5Q39900082-16E9B054-66CD-4003-B53A-6FCB08E15091Q39978795-CB4CFD26-1EB1-4BB1-83F5-5C61403FEC55Q40638051-9626584B-6E88-4612-B520-E6707A9AF038Q40875987-656F8C7B-5E6A-45DA-BE49-9DCB57D30E31Q42873668-455A0775-7615-49FA-8B3E-9A0927A81657Q43146159-549D5525-1D80-4F4E-89E0-62B1FB6FD0CDQ43551635-1F3AE3F6-DB3B-4869-9203-0FAA640976D6Q44032627-546293FB-97F4-4195-8F3D-19AC3A109676Q44223572-89F9D6EF-BC6B-4DEB-B267-4544DA935D5BQ44341098-3A392115-4B61-417C-AE5D-E21BA6B7D8C6Q44342229-13B75697-15EC-4DFF-84AF-06D3CFC84153Q44346075-483A9344-134C-4FA3-8078-ACDAB6A93C31Q44476644-FB3A8771-B40F-42C7-AA73-B02C6D406B2CQ45179041-CB47F2C9-0682-4735-9178-D16E27DBDBBBQ45238445-49A0CA1B-B939-42B6-98A7-D22211EF740DQ45858515-6AAB2BC5-43A8-476F-AA0C-8852FC4F7CD4Q46066841-5BEC50E5-69BE-47A4-9C77-2E9B0B113F84Q46151087-D5E23DD7-F6E3-4685-B864-BE47B04BC183Q46326723-8ACDD181-330A-465E-9DCA-C7D241733A81Q46338305-AFCAF7EA-E796-45BE-9729-2E646F9E43C9Q46410818-D79DAC0A-DEB5-4E96-862F-DB8F69EAA400Q46528535-FBD926B6-15B3-4DDB-AF6B-85E4E6F95EEEQ46596192-1F41AC7B-040E-4F07-A775-CE55D13FAC5DQ46601109-01363F1C-80CC-4F4E-A520-BE3045EA0574Q46684125-50FF8EDF-3AC4-4555-9364-553944E8A623Q46887630-87CDA0CC-CC75-40C7-BE6B-4272170F5AD2Q47306174-E47C1A52-6DF0-42C9-BF8B-6FE1622440E3Q47879941-63F7AC29-56C5-4616-98CA-5CF1F5A69B39Q48139240-8CC5C0ED-1647-4CF5-ABB6-D9136B5D23D8Q48143415-D8F6FBAE-07FF-45A6-87C8-AD2A562F7BD1Q48282329-58BC4FB8-D132-485F-B91A-50A40B35620CQ48342973-C97509E8-9959-4935-9025-31177EFEFDA1Q48360098-021FD604-1CAD-46BA-A7A6-745569A3CA94Q48397463-3C91B7EE-9D2C-4922-9DEA-EAF30B7863E0Q48500867-F4EF46C2-CC8E-463E-9AF0-44D861FC9A11
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luis F Alguacil
@es
Luis F Alguacil
@nl
Luis F Alguacil
@sl
Luis F. Alguacil
@en
type
label
Luis F Alguacil
@es
Luis F Alguacil
@nl
Luis F Alguacil
@sl
Luis F. Alguacil
@en
altLabel
Luis F Alguacil
@en
prefLabel
Luis F Alguacil
@es
Luis F Alguacil
@nl
Luis F Alguacil
@sl
Luis F. Alguacil
@en
P1053
J-6466-2016
P106
P1153
6701349294
P21
P31
P3829
P496
0000-0002-2542-5983